Bringing a wealth of experience in technology and healthcare investments, the fund manager has successfully executed over 50 deals across North America and Europe. With a thematic investing approach, they prioritize operator-first strategies, focusing on early to growth-stage companies. Their track record includes notable exits in the biotech sector, showcasing a keen ability to identify high-potential opportunities. This strategic style emphasizes data-driven decision-making, allowing for informed and impactful investments.